Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a blood or bone marrow cancer or related condition — including acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), high-risk myelodysplastic syndrome (HR-MDS), or myelofibrosis related to a blood disorder — and have not previously been treated for it
- People who have been informed about the study and do not object to taking part
- People who are covered by social security or any form of health insurance
Who may not be able to join:
- People whose leukaemia or related condition has not been confirmed through laboratory examination of cells or tissue (note: people with a type of tumour called granulocytic sarcoma may still be considered — confirm with trial site)
- People who have already received treatment for their blood condition, with some exceptions depending on their specific diagnosis — certain prior medications may be acceptable (confirm with trial site for the full list relevant to each condition)
- People who are under legal guardianship or a court-appointed protective arrangement
- People whose health coverage falls under a specific limited medical assistance scheme known as AME (confirm with trial site)
- People who object to being enrolled in the eTHEMA patient registry
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1 57 27 68 47
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Event Free Survival; Relapse Free Survival; Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.